Press Releases United Therapeutics Corporation

Equities

UTHR

US91307C1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
233.8 ^USD	-0.89%		-1.71%	+6.35%

Apr. 23	United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing	MT
Apr. 23	United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UNITED THERAPEUTICS ANNOUNCES WORLD'S FIRST SUCCESSFUL XENOTHYMOKIDNEY TRANSPLANT	Apr. 25	AQ
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant	Apr. 24	BU
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024	Apr. 24	BU
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference	Apr. 16	BU
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation	Mar. 26	BU
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program	Mar. 25	BU
The Printed Future Of Transplantology, Or How Science Fiction Became Reality	Mar. 19	AQ
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024	Mar. 05	BU
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 27	BU
United Therapeutics: Q4 Earnings Snapshot	Feb. 21	AQ
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 21	BU
United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process	Feb. 21	BU
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024	Feb. 14	BU
Spotlight On Upcoming Oral Arguments – February 2024	Feb. 13	AQ
Federal Circuit Evaluates Impact Of The Final Written Decision (FWD) In A Parallel Inter-Partes Review (IPR) On District Court's Decision Of Invalidity And Infringement	Jan. 02	AQ
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Dec. 29	BU
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger	Dec. 13	BU
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer	Dec. 12	BU
UNITED THERAPEUTICS NAMED BY NEWSWEEK AS ONE OF AMERICA'S MOST RESPONSIBLE COMPANIES 2024	Dec. 08	AQ
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024	Dec. 07	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases United Therapeutics Corporation

Equities

UTHR

US91307C1027

Press Releases

Filters